Monoclonal Antibody Treatment in Dogs

Lili Duda, VMD
Last Modified: August 22, 2007

Question:

Dear OncoLink "Ask the Experts,"
Please tell me about the use of Monoclonal Antibody Treatment for treating lymphoma in dogs once remission is achieved.

Answer:

UPDATE: Canine Lymphoma Monoclonal Antibody (CL/MAb 231), a specific protein directed against canine lymphoma cells, was used following a conventional chemotherapy regimen in an effort to prolong duration of remission (also known as "disease-free interval"). This product was produced by a company called Synbiotics, but has not been commercially available for many years.

You can learn more about veterinary clinical trials at the Veterinary Cancer Society's website.

Blogs

Bearer of Bad News
by Rodney Warner, JD
December 8, 2014

When A Beloved Pet Has Cancer… Interactive Webchat
by Carolyn Vachani, MSN, RN, AOCN
July 17, 2012

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
X
Y
Z
#
 
A
B
C
E
F
G
H
K
L
M
N
O
P
R
S
T
U
V
 
 
Stay informed with the latest information from OncoLink!   Subscribe to OncoLink eNews
View our newsletter archives